Stephen J. Carriere - Sep 29, 2021 Form 3 Insider Report for Evelo Biosciences, Inc. (EVLO)

Role
Principal Accounting Officer
Signature
/s/ Daniel S. Char, Attorney-in-Fact for Stephen J. Carriere
Stock symbol
EVLO
Transactions as of
Sep 29, 2021
Transactions value $
$0
Form type
3
Date filed
9/29/2021, 04:36 PM
Next filing
Jan 21, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EVLO Stock Option (Right to Buy) Sep 29, 2021 Common Stock 75K $11.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of underlying shares will vest on 1st anniversary of employment commencement date (i.e., September 1, 2022), and remaining 75% of underlying shares will vest in 36 substantially equal monthly installments thereafter.

Remarks:

Exhibit 24 - Power of Attorney